{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:35Z","timestamp":1790189975018,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Coexisting small cell lung cancer (SCLC) and hepatocellular carcinoma (HCC) is extraordinarily uncommon; in elderly patients with cardiac dysfunction it demands highly individualized, cardio-conscious care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 72-year-old man experienced an acute myocardial infarction in September 2019 and underwent emergency percutaneous coronary intervention. He had well-controlled hypertension and diabetes but no viral hepatitis history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Follow-up contrast computed tomography (December 2019) showed a 1.4 cm left-upper-lobe nodule and an 8 cm hepatic mass. Video-assisted biopsy confirmed stage IIIA SCLC (pT1N2M0). Right-hepatectomy pathology established primary HCC. Baseline echocardiography revealed New York Heart Association class III heart failure with left-ventricular ejection fraction of 40%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The multidisciplinary team performed thoracoscopic lobectomy with mediastinal dissection (January 2020) followed by right hepatectomy (November 2020). Adjuvant therapy was withheld because of severe cardiac compromise. On SCLC progression, the patient received 4 cycles of carboplatin\u2013etoposide, thoracic conformal radiotherapy, and atezolizumab maintenance. Concurrent cardio-oncology management \u2013 guideline-directed heart failure medication, serial echocardiography, and endocrinologic treatment of immune-related subclinical hypothyroidism \u2013 mitigated therapy-related toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient achieved a durable partial response lasting &gt;18 months. Left ventricular ejection fraction remained \u226540% after temporary decline, and immune adverse effects were controlled. Overall survival reached 39 months; he ultimately died of COVID-19 pneumonia in January 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Meticulous multidisciplinary team coordination can balance oncologic efficacy and cardioprotection, enabling meaningful survival for patients with simultaneous SCLC and HCC complicated by severe cardiac dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044341","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:02:58Z","timestamp":1757970178000},"page":"e44341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Multidisciplinary management of concurrent small cell lung cancer and hepatocellular carcinoma: A rare case report with long-term survival"],"prefix":"10.1097","volume":"104","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Hospital of Dalian Medical University Cardiovascular Hospital, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Chen","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9841-7171","authenticated-orcid":false,"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2020.23130","article-title":"Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States.","volume":"324","author":"Sung","year":"2020","journal-title":"JAMA"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review.","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"R3-20260923","first-page":"e44993","article-title":"Factors that determine multiple primary cancers in the adult population in the United States.","volume":"15","author":"Okeke","year":"2023","journal-title":"Cureus"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"1392969","DOI":"10.3389\/fonc.2024.1392969","article-title":"Diagnosis and management of multiple primary lung cancer.","volume":"14","author":"Dong","year":"2024","journal-title":"Front Oncol"},{"key":"R5-20260923","first-page":"e20185","article-title":"A case of metastatic non-small cell lung adenocarcinoma and metachronous primary hepatocellular carcinoma.","volume":"13","author":"Sidhom","year":"2021","journal-title":"Cureus"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer.","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer.","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.23.01435","article-title":"Systemic therapy for small-cell lung cancer: ASCO-Ontario health (Cancer Care Ontario) guideline.","volume":"41","author":"Khurshid","year":"2023","journal-title":"J Clin Oncol"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/biomedicines12020297","article-title":"Unraveling the potential of ALK-targeted therapies in non-small cell lung cancer: comprehensive insights and future directions.","volume":"12","author":"Parvaresh","year":"2024","journal-title":"Biomedicines"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Ganti","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cpt.2024.04.004","article-title":"Cardiotoxicity in platinum-based chemotherapy: mechanisms, manifestations, and management.","volume":"3","author":"Rachma","year":"2024","journal-title":"Cancer Pathog Ther"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"e2237699","DOI":"10.1001\/jamanetworkopen.2022.37699","article-title":"Comparison of carboplatin with cisplatin in small cell lung cancer in US veterans.","volume":"5","author":"Azar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R13-20260923","first-page":"363","article-title":"Consensus of Chinese experts on medical treatment of advanced lung cancer in the elderly (2022 edition).","volume":"25","year":"2022","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"R14-20260923","first-page":"177","article-title":"Consensus of Chinese experts on nursing of lung cancer in the elderly (2022 edition).","volume":"26","year":"2023","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/DDDT.S443107","article-title":"Understanding sorafenib-induced cardiovascular toxicity: mechanisms and treatment implications.","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"1291180","DOI":"10.3389\/fcvm.2024.1291180","article-title":"Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain.","volume":"11","author":"Nhat","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology state-of-the-art review.","volume":"6","author":"Camilli","year":"2024","journal-title":"JACC CardioOncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:02:54Z","timestamp":1790186574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":17,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044341","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2025-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}